IRS1 and gestational diabetes: In pregnancies associated with GDM, there is a notable increase in adipocyte fatty acid binding protein (FABP) expression and a decrease in peroxisome proliferator-activated receptor gamma (PPARγ) expression, along with chronic inflammation due to defective insulin receptor substrate-1 (IRS-1) function and insulin receptor phosphorylation [6].